Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors within the central anxious technique, conolidine modulates alternate molecular targets. A Science Advancements research identified that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid pept... https://johno099akn4.wikiap.com/user